Predictive utility of the NEO-FFI for later substance experiences among 16-year-old adolescents
- 217 Downloads
The onset of substance use mostly occurs during adolescence. The aim of the present study is to investigate the relevance of personality on the basis of the NEO-Five-Factor Inventory (NEO-FFI) to future experiences with tobacco, alcohol and cannabis.
The test data were derived from the baseline assessment and first follow-up of the IMAGEN study, a European multicenter and multidisciplinary research project on adolescent mental health. In the present study 1004 participants were tested. The characterization of personality was conducted with the NEO-FFI at the age of 14 (T1). The data on substance use were collected with the European School Survey Project on Alcohol and Other Drugs (ESPAD) questionnaire at the age of 16 (T2). For the statistical analysis, t-tests and univariate analyses of variance were performed.
The scores of Conscientiousness at T1 were significantly lower for adolescents with tobacco, alcohol and cannabis experiences at T2. We found lower scores of Agreeableness at T1 in participants with tobacco and cannabis use at T2. Extraversion at T1 was significantly higher for adolescents with smoking experiences at T2. No significant associations between Neuroticism or Openness and future substance use were observed.
Low scores of Conscientiousness and Agreeableness seem to have the greatest value for a prediction of later experiences with substance use. As the present study is the first one to examine the predictive value of the NEO-FFI for future substance use in an adolescent sample, further studies are necessary to enable a better applicability in a clinical context.
KeywordsAdolescence Personality Five-factor model of personality NEO-FFI Substance use
This work received support from the following sources: the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behaviour in normal brain function and psychopathology) (LSHM-CT- 2007–037286), the FP7 projects IMAGEMEND (602450; IMAgingGEnetics for MENtal Disorders) and MATRICS (603016), the Innovative Medicine Initiative Project EU-AIMS (115300–2), a Medical Research Council Programme Grant “Developmental pathways into adolescent substance abuse” (93558), the Swedish funding agency FORMAS, the Medical Research Council and the Wellcome Trust (Behavioural and Clinical Neuroscience Institute, University of Cambridge), the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, the Bundesministerium für Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; eMED SysAlc01ZX1311A;Forschungsnetz AERIAL), the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-1, SM 80/7-2, SFB 940/1) and the National Institutes of Health, USA (Axon, Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1).
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interest.
- Centers for Disease Control & Prevention (2008) Smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 2000–2004. MMWR Morb Mortal Wkly Rep 57(45):1226–1228Google Scholar
- Gallinat J, Meisenzahl E, Jacobsen LK, Kalus P, Bierbrauer J, Kienast T, Witthaus H, Leopold K, Seifert F, Schubert F, Staedtgen M (2006) Smoking and structural brain deficits: a volumetric MR investigation. Eur J Neurosci 24(6):1744–1750. doi: 10.1111/j.1460-9568.2006.05050.x CrossRefPubMedGoogle Scholar
- Hibell B, Andersson B, Ahlström S, Balakireva O, Bjarnason T, Kokkevi A, Morgan M (2000) The 1999 ESPAD report. Alcohol and other drug use among students in 30 European Countries. The Swedish Council for Information on Alcohol and Other Drugs, StockholmGoogle Scholar
- Hibell B, Andersson B, Bjarnason T, Ahlström S, Balakireva O, Kokkevi A, Morgan M (2004) The ESPAD report 2003. Alcohol and other drug use among students in 35 European countries. The Swedish Council for Information on Alcohol and Other Drugs, StockholmGoogle Scholar
- Hinckers AS, Laucht M, Schmidt MH, Mann KF, Schumann G, Schuckit MA, Heinz A (2006) Low level of response to alcohol as associated with serotonin transporter genotype and high alcohol intake in adolescents. Biol Psychiatry 60(3):282–287. doi: 10.1016/j.biopsych.2005.12.009 CrossRefPubMedGoogle Scholar
- Schumann G, Loth E, Banaschewski T, Barbot A, Barker G, Buchel C, Conrod PJ, Dalley JW, Flor H, Gallinat J, Garavan H, Heinz A, Itterman B, Lathrop M, Mallik C, Mann K, Martinot JL, Paus T, Poline JB, Robbins TW, Rietschel M, Reed L, Smolka M, Spanagel R, Speiser C, Stephens DN, Strohle A, Struve M, and The IMAGEN consortium (2010) The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry 15(12):1128–1139. doi: 10.1038/mp.2010.4 CrossRefPubMedGoogle Scholar
- Whelan R, Watts R, Orr CA, Althoff RR, Artiges E, Banaschewski T, Barker GJ, Bokde AL, Buchel C, Carvalho FM, Conrod PJ, Flor H, Fauth-Buhler M, Frouin V, Gallinat J, Gan G, Gowland P, Heinz A, Ittermann B, Lawrence C, Mann K, Martinot JL, Nees F, Ortiz N, Paillere-Martinot ML, Paus T, Pausova Z, Rietschel M, Robbins TW, Smolka MN, Strohle A, Schumann G, Garavan H, The IMAGEN consortium (2014) Neuropsychosocial profiles of current and future adolescent alcohol misusers. Nature 512(7513):185–189. doi: 10.1038/nature13402 CrossRefPubMedPubMedCentralGoogle Scholar